FAP and ovarian neoplasm: As such, TGFβ-secreting myCAF is very abundant in immune-excluded ovarian tumors [153], and αSMA+FAP+ CAFs from head and neck tumors have been shown to inhibit CD8+ T cell proliferation and to promote the recruitment of Tregs in a TGFβ-dependent manner [154].